🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
The purpose of this study is to compare the efficacy of ciltacabtagene auto...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-06-12
Trial ID
NCT04181827
Treatments Being Tested
This is an open label Phase II study to determine the rate of improvement i...
Status
Completed
Location
University of Maryland Medical Center - M & S Greenebaum Cancer Center
Start Date
2010-11
Trial ID
NCT01242930
Treatments Being Tested
This is a Phase 1a/1b, multicenter, open-label, two-part study in subjects ...
Status
Completed
Location
The University of Texas MD Anderson Cancer Center
Start Date
2015-10-19
Trial ID
NCT02426723
Treatments Being Tested
This is an open-label, multicentre, dose escalation study to characterize t...
Status
Completed
Location
AKH (Allgemeines Krankenhaus der Stadt Wien), Abteilung für Klinische Onkologie, Universitätsklinik für Innere Medizin I
Start Date
2011-07
Trial ID
NCT01421186
Treatments Being Tested
This is a study of pembrolizumab (MK-3475) in combination with lenalidomide...
Status
Terminated
Location
Multiple Locations
Start Date
2014-02-14
Trial ID
NCT02036502
Treatments Being Tested
The purpose of this study is to compare the effects, good and bad, of two w...
Status
Completed
Location
Memoral Sloan Kettering Cancer Center
Start Date
2008-12-10
Trial ID
NCT00807599
Treatments Being Tested
This is a randomized, open label, multicenter phase III trial comparing the...
Status
Completed
Location
Moores UC San Diego Cancer Center
Start Date
2019-05-09
Trial ID
NCT03570892
The goal of this clinical research study is to learn if Revlimid® (lenalido...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2008-04
Trial ID
NCT00675441
Treatments Being Tested
This trial will compare tisagenlecleucel to standard of care in adult parti...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2023-10-02
Trial ID
NCT05888493
Treatments Being Tested